Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
NCT06522737· Phase 3· SecuraBio· Source
Contact: Kate Cwynarski (principal investigator)
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error